SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001012168-97-000017
Filing Date
1997-05-09
Accepted
1997-05-09 00:00:00
Documents
1
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 SC 13D/A 45586
  Complete submission text file 0001012168-97-000017.txt   47677
Mailing Address 2525 DUPONT DR IRVINE CA 92715
Business Address 9393 TOWNE CENTER DR SAN DIEGO CA 92121 6195353900
ALLERGAN LIGAND RETINOID THERAPEUTICS INC (Subject) CIK: 0000934592 (see all company filings)

IRS No.: 330642614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-45829 | Film No.: 97599411
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE MARITIME PLAZA SUITE 1325 SAN FRANCISCO CA 94111
Business Address ONE MARITIME PLZ STE 1325 SAN FRANCISCO CA 94111 4154212132
FARALLON CAPITAL MANAGEMENT LLC /ADV (Filed by) CIK: 0001012168 (see all company filings)

IRS No.: 943240279 | State of Incorp.: DE | Fiscal Year End: 1231